Nothing makes you feel more vulnerable at work than sharing a life-altering health diagnosis, especially as a leader who is ...

Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer. With an excellent prognosis and a curable ...

Nonetheless, the CEO of the world’s largest IT company will lead its day-to-day operations throughout the process.

Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff that “the prognosis from my doctor is excellent; the cancer was caught ...

However, the CEO will continue to look after the day-to-day operations of the IT services and consulting firm during the ...

Today, Accenture plc (NYSE:ACN), a $243 billion market cap technology consulting giant, disclosed an update on the health of Julie Sweet, the company's Chair and Chief Executive Officer.

Accenture CEO Julie Sweet was praised this week for her openness regarding a breast cancer diagnosis, which also gave rare ...

Accenture has scrapped its global diversity and inclusion goals after an evaluation of the changing U.S. political landscape, ...

CEO Julie Sweet said the company would end its employee diversity representation goals and put “a greater focus on inclusion ...